Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Health Resources and Services Administration
Providers
Hospitals decry drugmakers' expanded 340B reporting policies
Eli Lilly and now Novo Nordisk have outlined expanded reporting policies hospitals say are unlawful and burdensome. The HRSA has yet to weigh in.
Dave Muoio
Mar 4, 2026 5:00pm
In 1 state, large hospitals dominate 340B's net savings
Mar 2, 2026 5:30pm
Trump administration restarts its efforts to pilot 340B rebates
Feb 13, 2026 1:00pm
HHS agrees to toss 340B Rebate Model Pilot Program
Feb 6, 2026 11:00am
HRSA approves 8 drugmakers' rebate plans for 340B pilot program
Oct 31, 2025 5:00pm
AHA: 340B pilot's reporting burdens far outstrip gov's estimates
Oct 2, 2025 10:00am
